MAT, a Novel Polyherbal Aphrodisiac Formulation, Enhances Sexual Function and Nrf2/HO-1 Pathway While Reducing Oxidative Damage in Male Rats
Table 1
The effects of extracts on final body weight and absolute and relative reproductive organ weights.
Item
Groups
Control
Sildenafil
MAT I
MAT II
Final body weight, g
267.00 ± 4.57
254.67 ± 10.26
262.50 ± 12.65
260.83 ± 9.44
Testis, g
1.178 ± 0.017
1.174 ± 0.029
1.227 ± 0.068
1.257 ± 0.058
Whole epididymis, g
0.473 ± 0.007
0.468 ± 0.020
0.462 ± 0.018
0.418 ± 0.015
Right cauda epididymis, g
0.170 ± 0.003
0.172 ± 0.005
0.185 ± 0.014
0.175 ± 0.010
Vas deferens, g
0.109 ± 0.004
0.112 ± 0.008
0.118 ± 0.010
0.117 ± 0.012
Seminal vesicles, g
1.313 ± 0.094
1.575 ± 0.070
1.508 ± 0.089
1.203 ± 0.050
Ventral prostate, g
0.408 ± 0.027
0.478 ± 0.037
0.565 ± 0.027
0.528 ± 0.026
Testis, %
0.442 ± 0.011
0.460 ± 0.022
0.469 ± 0.022
0.483 ± 0.020
Whole epididymis, %
0.178 ± 0.003
0.184 ± 0.012
0.178 ± 0.009
0.185 ± 0.007
Right Cauda epididymis, %
0.064 ± 0.001
0.067 ± 0.004
0.071 ± 0.004
0.067 ± 0.003
Vas deferens, %
0.041 ± 0.002
0.044 ± 0.003
0.045 ± 0.003
0.045 ± 0.004
Seminal vesicles, %
0.493 ± 0.037
0.621 ± 0.026
0.577 ± 0.030
0.462 ± 0.013
Ventral prostate, %
0.153 ± 0.009
0.187 ± 0.010
0.217 ± 0.011
0.204 ± 0.014
Relative reproductive organ weights [organ weight (g)/final body weight (g) × 100]; data are means ± SE. Different superscripts (a–c) indicate group mean differences (P < 0.05).
